Background High-grade glioma has a poor overall survival with profoundly negative effects
on the patient's quality of life and their caregivers. In this study, we investigate the factors …

Glioblastoma comprises more than half of all malignant gliomas and represents the most
common primary brain tumor in adults. The incidence of glioblastoma peaks between the 7th …

Glioblastoma (GBM) is the most common primary malignant tumor of the central nervous
system, accounting for 48.3% of primary malignant brain tumors and 57.3% of all gliomas …

Glioblastoma is the most malignant and most common primary brain tumour and is treated
with resection followed by post-operative radiotherapy and chemotherapy. However, a …

Objective Glioblastoma (GBM) is the commonest primary malignant brain tumour amongst
the adult population. Incidence peaks in the 7th and 8th decades of life and as our global …

OBJECTIVE Approximately half of glioblastoma (GBM) cases develop in geriatric patients,
and this trend is destined to increase with the aging of the population. The optimal strategy …

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults, and over
half of patients with newly diagnosed GBM are over the age of 65. Management of …

Aims Many elderly glioblastoma patients are excluded from randomised trials due to age,
comorbidity or poor functional status. The purpose of this study was to describe the survival …

Background Elderly patients with glioblastoma are perceived to face a poor prognosis with
perceptions surrounding older age and a relative lack of randomized data contributing. This …

Editorial 114 the time toxicity of cancer treatment by providing data on hospital utilization,
which is not typically evaluated in clinical trials but is relevant in patients with limited time …